Biotechnology Featured Health Law Policy Intellectual Property International Pharmaceuticals Public Health Resource Allocation Vaccines
Intellectual Property
-
-
Biotechnology Chloe Reichel Featured Health Law Policy Intellectual Property Pharmaceuticals Vaccines4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines
Read more: 4 Things to Know About Intellectual Property, Patent Pledges, and COVID-19 Vaccines -
Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported?
Read more: Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported? -
When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims -
Year in Review: Biosimilars
Read more: Year in Review: Biosimilars -
Clash of Titans? A Brewing Dispute between Telehealth Giants
Read more: Clash of Titans? A Brewing Dispute between Telehealth Giants -
Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check -
Biotechnology Featured Health Law Policy Intellectual Property Jorge Contreras Public Health VaccinesDeconstructing Moderna’s COVID-19 Patent Pledge
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge -
Biotechnology FDA Featured Health Law Policy Intellectual Property Jorge Contreras Medical devices Public HealthPatent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy
Read more: Patent Fakes: How Fraudulent Inventions Threaten Public Health, Innovation, and the Economy -
COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies
Read more: COVID-19 Highlights Need for Rights to Repair and Produce in Emergencies